USAntibiotics Plans Bristol, Tennessee, Research-Manufacturing Campus
09/03/2021
Located at 201 Industrial Drive, the 360,000-square-foot facility was acquired by Jackson Healthcare with plans to re-open the former pharmaceutical manufacturing site.
“USAntibiotics is focused on what it does best, producing life-saving antibiotics and making them accessible to all Americans. We are proud to have our operations in the state of Tennessee and of the role we play in manufacturing high-quality, made in America products that support health and wellness and that reduce our dependence on vital medications produced outside our country” said Rick Jackson, CEO, Jackson Healthcare, parent company of USAntibiotics.
“We are proud to support USAntibiotics in its critical mission to manufacture two of the most commonly prescribed antibiotics in the country. Tennessee offers companies around the globe a business-friendly climate and skilled workforce, and we are pleased to welcome USAntibiotics to the state as it sets up new operations in Sullivan County,” noted TNECD Commissioner Bob Rolfe.
The Department of Homeland Security has identified USAntibiotics as critical infrastructure since it is the only manufacturing facility in the United States that is authorized to produce Amoxicillin and Amoxicillin Clavulanate, commonly known as Amoxil and Augmentin. These are two of the most widely prescribed antibiotics in the U.S. and this investment will greatly bolster the U.S.’ capabilities to produce its own essential antibiotics.
“We are known for being a leader in a lot of things here, the Birthplace of Country Music, the first public utility to win a Malcolm Baldrige Award with BTES, the World’s Fastest Half Mile at Bristol Motor Speedway, so why not Bristol, Tennessee as the reshoring center of our nation’s antibiotic production. It’s this culture, particularly in our workforce, that was the real difference maker in attracting US Antibiotics. This is a great fit of a company and a community and I’m excited to see all of the great things the future has in store for US Antibiotics, Bristol and Northeast Tennessee,” said David Wagner, Bristol Industrial Development Board chairman, vice-chairman of NETWORKS Sullivan County Partnership.
Project Announcements
ValorFlex Packaging Plans Bowling Green, Kentucky, Production Operations
06/30/2025
Neuro.io Plans Terrebonne Parish, Louisiana, Operations
06/30/2025
Germany-Based MTU Maintenance Expands Fort Worth, Texas, MRO Operations
06/30/2025
Cascade Die Casting Group Expands High Point, North Carolina, Manufacturing Operations
06/30/2025
BuildOps Plans Raleigh, North Carolina, Operations
06/30/2025
Point Blank Enterprises Plans Wakulla County, Florida, Operations
06/30/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024